776 related articles for article (PubMed ID: 11236776)
41. Risk factors for delayed graft function defined as need for dialysis or failure of creatinine to fall by 10% in the first 24 hours after transplant.
Stratopoulos C; Roberts IS; Brockmann J; Zilvetti M; Muthusamy A; Vaidya A; Sinha S; Friend PJ
Exp Clin Transplant; 2008 Mar; 6(1):37-41. PubMed ID: 18405243
[TBL] [Abstract][Full Text] [Related]
42. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
43. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
[TBL] [Abstract][Full Text] [Related]
44. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
[TBL] [Abstract][Full Text] [Related]
45. Living or deceased donor kidney transplantation: a comparison of results and survival rates among Iranian patients.
Naderi GH; Mehraban D; Kazemeyni SM; Darvishi M; Latif AH
Transplant Proc; 2009 Sep; 41(7):2772-4. PubMed ID: 19765431
[TBL] [Abstract][Full Text] [Related]
46. Preemptive transplantation for patients with diabetes-related kidney disease.
Becker BN; Rush SH; Dykstra DM; Becker YT; Port FK
Arch Intern Med; 2006 Jan; 166(1):44-8. PubMed ID: 16401809
[TBL] [Abstract][Full Text] [Related]
47. Risk factors on graft survival of living donor kidney transplantation.
Park YH; Min SK; Lee JN; Lee HH; Jung WK; Lee JS; Lee JH; Lee YD
Transplant Proc; 2004 Sep; 36(7):2023-5. PubMed ID: 15518732
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
49. Kidney transplantation in patients with a prior heart transplant.
Cassuto JR; Reese PP; Bloom RD; Doyle A; Goral S; Naji A; Abt PL
Transplantation; 2010 Feb; 89(4):427-33. PubMed ID: 20177344
[TBL] [Abstract][Full Text] [Related]
50. Acute respiratory distress syndrome after kidney transplantation: epidemiology, risk factors, and outcomes.
Shorr AF; Abbott KC; Agadoa LY
Crit Care Med; 2003 May; 31(5):1325-30. PubMed ID: 12771598
[TBL] [Abstract][Full Text] [Related]
51. Clinical outcome of preemptive kidney transplantation in patients with diabetes mellitus.
Son YK; Oh JS; Kim SM; Jeon JM; Shin YH; Kim JK
Transplant Proc; 2010 Nov; 42(9):3497-502. PubMed ID: 21094803
[TBL] [Abstract][Full Text] [Related]
52. Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium.
Heldal K; Hartmann A; Leivestad T; Foss A; Midtvedt K
Nephrol Dial Transplant; 2011 Aug; 26(8):2706-11. PubMed ID: 21285131
[TBL] [Abstract][Full Text] [Related]
53. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
Garg PP; Frick KD; Diener-West M; Powe NR
N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
[TBL] [Abstract][Full Text] [Related]
54. Delayed graft function, allograft and patient srvival in kidney transplantation.
Ghadiani MH; Peyrovi S; Mousavinasab SN; Jalalzadeh M
Arab J Nephrol Transplant; 2012 Jan; 5(1):19-24. PubMed ID: 22283862
[TBL] [Abstract][Full Text] [Related]
55. Impact of cold ischemia time on initial graft function and survival rates in renal transplants from deceased donors performed in Andalusia.
Pérez Valdivia MA; Gentil MA; Toro M; Cabello M; Rodríguez-Benot A; Mazuecos A; Osuna A; Alonso M
Transplant Proc; 2011; 43(6):2174-6. PubMed ID: 21839225
[TBL] [Abstract][Full Text] [Related]
56. Recurrent IgA nephropathy in renal transplant allografts.
Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
[TBL] [Abstract][Full Text] [Related]
57. Advantages of kidney transplant precocity in graft long-term survival.
Malho A; Malheiro J; Fonseca I; Martins LS; Pedroso S; Almeida M; Dias L; Castro Henriques A; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2344-7. PubMed ID: 23026589
[TBL] [Abstract][Full Text] [Related]
58. Does donor kidney to recipient body weight ratio influence long-term outcomes of living-donor kidney transplantation?
Hwang JK; Kim YK; Kim SD; Park SC; Choi BS; Kim JI; Yang CW; Kim YS; Moon IS
Transplant Proc; 2012 Jan; 44(1):276-80. PubMed ID: 22310632
[TBL] [Abstract][Full Text] [Related]
59. The natural history of chronic allograft nephropathy.
Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
[TBL] [Abstract][Full Text] [Related]
60. Effect of pretransplant dialysis modality and duration on long-term outcomes of children receiving renal transplants.
Butani L; Perez RV
Transplantation; 2011 Feb; 91(4):447-51. PubMed ID: 21131898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
